{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T15:02:48Z","timestamp":1793026968811,"version":"4.5.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"51","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation \u2013 Republic of Korea","doi-asserted-by":"crossref","award":["NRF-2015R1 A2 A1 A10052511"],"award-info":[{"award-number":["NRF-2015R1 A2 A1 A10052511"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.vaccine.2016.10.071","type":"journal-article","created":{"date-parts":[[2016,11,17]],"date-time":"2016-11-17T02:00:46Z","timestamp":1479348046000},"page":"6481-6492","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Pneumococcal pep27 mutant immunization stimulates cytokine secretion and confers long-term immunity with a wide range of protection, including against non-typeable strains"],"prefix":"10.1016","volume":"34","author":[{"given":"Gyu-Lee","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Yoon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Han","family":"Seon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seungyeop","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Sang","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joon Young","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Briles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Kwon","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.10.071_b0005","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/nrmicro1871","article-title":"The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease","volume":"6","author":"Kadioglu","year":"2008","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2016.10.071_b0010","first-page":"189","article-title":"Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention","volume":"vol. 30","author":"Lynch","year":"2009"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2016.10.071_b0015","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1086\/596487","article-title":"Use of multiple surveillance modalities to assess the epidemiology of Streptococcus pneumoniae infection in Bangladesh","volume":"48","author":"Luby","year":"2009","journal-title":"Clin Infectious Diseases: Off Publ Infectious Diseases Soc Am"},{"key":"10.1016\/j.vaccine.2016.10.071_b0020","doi-asserted-by":"crossref","first-page":"6164","DOI":"10.1016\/j.vaccine.2007.06.004","article-title":"Phase 1 trial of a 13-valent pneumococcal conjugate vaccine in healthy adults","volume":"25","author":"Scott","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.10.071_b0025","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1086\/606047","article-title":"Pneumococcal conjugate vaccine, polysaccharide vaccine, or both for adults? We\u2019re not there yet","volume":"49","author":"O\u2019Brien","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2016.10.071_b0030","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/00006454-199506000-00007","article-title":"Potential interventions for the prevention of childhood pneumonia: geographic and temporal differences in serotype and serogroup distribution of sterile site pneumococcal isolates from children\u2013implications for vaccine strategies","volume":"14","author":"Sniadack","year":"1995","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2016.10.071_b0035","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/jac\/dkr048","article-title":"Predominance of ST320 among Streptococcus pneumoniae serotype 19A isolates from 10 Asian countries","volume":"66","author":"Shin","year":"2011","journal-title":"J Antimicrobial Chemotherapy"},{"issue":"886","key":"10.1016\/j.vaccine.2016.10.071_b0040","first-page":"e1","article-title":"Pneumococcal vaccine and patients with pulmonary diseases","volume":"127","author":"Mirsaeidi","year":"2014","journal-title":"Am J Med"},{"key":"10.1016\/j.vaccine.2016.10.071_b0045","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1007\/s00018-012-1234-8","article-title":"Serotype-independent pneumococcal vaccines","volume":"70","author":"Miyaji","year":"2013","journal-title":"Cell Mol Life Sci: CMLS"},{"key":"10.1016\/j.vaccine.2016.10.071_b0050","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000365052","article-title":"Recent approaches in vaccine development against Streptococcus pneumoniae","volume":"24","author":"Tarahomjoo","year":"2014","journal-title":"J Mol Microbiol Biotechnol"},{"key":"10.1016\/j.vaccine.2016.10.071_b0055","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1016\/j.vaccine.2014.05.019","article-title":"Mucosal and systemic immunization with a novel attenuated pneumococcal vaccine candidate confer serotype independent protection against Streptococcus pneumoniae in mice","volume":"32","author":"Wu","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.10.071_b0060","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1128\/IAI.01972-06","article-title":"Live attenuated Streptococcus pneumoniae strains induce serotype-independent mucosal and systemic protection in mice","volume":"75","author":"Roche","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.10.071_b0065","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1073\/pnas.1121383109","article-title":"Serotype-independent pneumococcal experimental vaccines that induce cellular as well as humoral immunity","volume":"109","author":"Malley","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2016.10.071_b0070","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.1128\/IAI.67.9.4320-4325.1999","article-title":"Intranasal immunization with heat-inactivated Streptococcus pneumoniae protects mice against systemic pneumococcal infection","volume":"67","author":"Hvalbye","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.10.071_b0075","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa030595","article-title":"Use of the inactivated intranasal influenza vaccine and the risk of Bell\u2019s palsy in Switzerland","volume":"350","author":"Mutsch","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2016.10.071_b0080","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.addr.2005.12.003","article-title":"Needle-free vaccine delivery","volume":"58","author":"Giudice","year":"2006","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2016.10.071_b0085","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1086\/379665","article-title":"Epidemiology of acute otitis media caused by Streptococcus pneumoniae before and after licensure of the 7-valent pneumococcal protein conjugate vaccine","volume":"188","author":"McEllistrem","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.10.071_b0090","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1586\/14760584.5.5.651","article-title":"Nasopharyngeal colonization: a target for pneumococcal vaccination","volume":"5","author":"Kayhty","year":"2006","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2016.10.071_b0095","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1586\/14760584.6.3.419","article-title":"Intranasal vaccines for protection against respiratory and systemic bacterial infections","volume":"6","author":"Oliveira","year":"2007","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2016.10.071_b0100","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.vaccine.2011.11.073","article-title":"Streptococcus pneumoniae pep27 mutant as a live vaccine for serotype-independent protection in mice","volume":"30","author":"Kim","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.10.071_b0105","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.vaccine.2015.01.014","article-title":"Trivalent pneumococcal protein recombinant vaccine protects against lethal Streptococcus pneumoniae pneumonia and correlates with phagocytosis by neutrophils during early pathogenesis","volume":"33","author":"Xu","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.10.071_b0110","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/jlb.65.5.671","article-title":"MCP-1 is selectively expressed in the late phase by cytokine-stimulated human neutrophils: TNF-alpha plays a role in maximal MCP-1 mRNA expression","volume":"65","author":"Yamashiro","year":"1999","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.vaccine.2016.10.071_b0115","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1399-302X.2008.00484.x","article-title":"Relationship of neutrophil phagocytosis and oxidative burst with the subgingival microbiota of generalized aggressive periodontitis","volume":"24","author":"Carvalho","year":"2009","journal-title":"Oral Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2016.10.071_b0120","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.4049\/jimmunol.1302692","article-title":"Phagocytosis of Staphylococcus aureus by human neutrophils prevents macrophage efferocytosis and induces programmed necrosis","volume":"192","author":"Greenlee-Wacker","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2016.10.071_b0125","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1073\/pnas.1315606111","article-title":"CD28 and CD3 have complementary roles in T-cell traction forces","volume":"111","author":"Bashour","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2016.10.071_b0130","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.vaccine.2013.10.080","article-title":"A modified surface killing assay (MSKA) as a functional in vitro assay for identifying protective antibodies against pneumococcal surface protein A (PspA)","volume":"32","author":"Genschmer","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.10.071_b0135","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nri1777","article-title":"Mucosal vaccines: the promise and the challenge","volume":"6","author":"Neutra","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2016.10.071_b0140","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1111\/irv.12124","article-title":"Intranasal influenza vaccination using a new synthetic mucosal adjuvant SF-10: induction of potent local and systemic immunity with balanced Th1 and Th2 responses","volume":"7","author":"Kimoto","year":"2013","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.vaccine.2016.10.071_b0145","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1128\/IAI.65.7.2975-2977.1997","article-title":"Role of gamma interferon in the pathogenesis of bacteremic pneumococcal pneumonia","volume":"65","author":"Rubins","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.10.071_b0150","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1128\/IAI.01403-06","article-title":"Interleukin-12 promotes gamma interferon-dependent neutrophil recruitment in the lung and improves protection against respiratory Streptococcus pneumoniae infection","volume":"75","author":"Sun","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.10.071_b0155","doi-asserted-by":"crossref","first-page":"e1000159","DOI":"10.1371\/journal.ppat.1000159","article-title":"Interleukin-17A mediates acquired immunity to pneumococcal colonization","volume":"4","author":"Lu","year":"2008","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2016.10.071_b0160","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/mi.2014.95","article-title":"Protection against Streptococcus pneumoniae lung infection after nasopharyngeal colonization requires both humoral and cellular immune responses","volume":"8","author":"Wilson","year":"2015","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.vaccine.2016.10.071_b0165","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.immuni.2004.08.018","article-title":"Interleukin-17 family members and inflammation","volume":"21","author":"Kolls","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2016.10.071_b0170","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1128\/IAI.00832-08","article-title":"Neutrophil recruitment to the lungs during bacterial pneumonia","volume":"77","author":"Craig","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.10.071_b0175","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1586\/erv.11.14","article-title":"Long-term protection after immunization with protein-polysaccharide conjugate vaccines in infancy","volume":"10","author":"Blanchard-Rohner","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2016.10.071_b0180","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1093\/infdis\/jir657","article-title":"Sex-based differences in susceptibility to respiratory and systemic pneumococcal disease in mice","volume":"204","author":"Kadioglu","year":"2011","journal-title":"J Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2016.10.071_b0185","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/S0264-410X(99)00122-X","article-title":"The burden of pneumococcal disease among adults in developed and developing countries: what is and is not known","volume":"17","author":"Fedson","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.10.071_b0190","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S1473-3099(03)00514-0","article-title":"Efficacy of polysaccharide pneumococcal vaccine in adults in more developed countries: the state of the evidence","volume":"3","author":"Mangtani","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2016.10.071_b0195","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","article-title":"Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children","volume":"19","author":"Black","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2016.10.071_b0200","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3346\/jkms.2013.28.1.4","article-title":"Clinical implications of pneumococcal serotypes: invasive disease potential, clinical presentations, and antibiotic resistance","volume":"28","author":"Song","year":"2013","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.vaccine.2016.10.071_b0205","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0140-6736(05)71876-6","article-title":"Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial","volume":"365","author":"Cutts","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.10.071_b0210","doi-asserted-by":"crossref","first-page":"4316","DOI":"10.1016\/j.vaccine.2012.01.034","article-title":"Broad antibody and T cell reactivity induced by a pneumococcal whole-cell vaccine","volume":"30","author":"Moffitt","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.10.071_b0215","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1476-8518-9-5","article-title":"Formulation of a killed whole cell pneumococcus vaccine - effect of aluminum adjuvants on the antibody and IL-17 response","volume":"9","author":"Hogenesch","year":"2011","journal-title":"J Immune Based Therapies Vaccines"},{"key":"10.1016\/j.vaccine.2016.10.071_b0220","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1128\/CVI.00692-14","article-title":"Evaluation of a vaccine formulation against Streptococcus pneumoniae based on choline-binding proteins","volume":"22","author":"Miyaji","year":"2015","journal-title":"Clin Vaccine Immunol: CVI"},{"key":"10.1016\/j.vaccine.2016.10.071_b0225","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1146\/annurev.micro.51.1.311","article-title":"Interaction of antigens and antibodies at mucosal surfaces","volume":"51","author":"Lamm","year":"1997","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.vaccine.2016.10.071_b0230","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1749-6632.1996.tb21115.x","article-title":"The role of Th1 and Th2 cells for mucosal IgA responses","volume":"778","author":"Yamamoto","year":"1996","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.vaccine.2016.10.071_b0235","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/nri3523","article-title":"The immune system and kidney disease: basic concepts and clinical implications","volume":"13","author":"Kurts","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2016.10.071_b0240","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1128\/CMR.18.3.541-555.2005","article-title":"Immune responses and disease enhancement during respiratory syncytial virus infection","volume":"18","author":"Openshaw","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2016.10.071_b0245","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/mi.2014.95","article-title":"Protection against Streptococcus pneumoniae lung infection after nasopharyngeal colonization requires both humoral and cellular immune responses","volume":"8","author":"Wilson","year":"2015","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.vaccine.2016.10.071_b0250","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s10753-010-9255-7","article-title":"Comparison of pulmonary inflammatory and antioxidant responses to intranasal live and heat-killed Streptococcus pneumoniae in mice","volume":"34","author":"Dominis-Kramaric","year":"2011","journal-title":"Inflammation"},{"key":"10.1016\/j.vaccine.2016.10.071_b0255","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/S0264-410X(98)00441-1","article-title":"Killed whole bacterial cells, a mucosal delivery system for the induction of immunity in the respiratory tract and middle ear: an overview","volume":"17","author":"Kyd","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.10.071_b0260","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1128\/IAI.01110-09","article-title":"Toll-like receptor stimulation enhances phagocytosis and intracellular killing of nonencapsulated and encapsulated Streptococcus pneumoniae by murine microglia","volume":"78","author":"Ribes","year":"2010","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.10.071_b0265","doi-asserted-by":"crossref","first-page":"6718","DOI":"10.1128\/IAI.69.11.6718-6724.2001","article-title":"Intranasal vaccination with pneumococcal surface protein A and interleukin-12 augments antibody-mediated opsonization and protective immunity against Streptococcus pneumoniae infection","volume":"69","author":"Arulanandam","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.10.071_b0270","doi-asserted-by":"crossref","first-page":"e1001017","DOI":"10.1371\/journal.pmed.1001017","article-title":"Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study","volume":"8","author":"Flasche","year":"2011","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2016.10.071_b0275","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3345\/kjp.2014.57.2.55","article-title":"Efficacy and effectiveness of extended-valency pneumococcal conjugate vaccines","volume":"57","author":"Lee","year":"2014","journal-title":"Korean J Pediatrics"},{"key":"10.1016\/j.vaccine.2016.10.071_b0280","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1086\/503805","article-title":"Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease","volume":"193","author":"Hammitt","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.10.071_b0285","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1542\/peds.2008-3099","article-title":"Continued impact of pneumococcal conjugate vaccine on carriage in young children","volume":"124","author":"Huang","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2016.10.071_b0290","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1128\/IAI.65.4.1237-1244.1997","article-title":"Differences in virulence for mice among Streptococcus pneumoniae strains of capsular types 2, 3, 4, 5, and 6 are not attributable to differences in pneumolysin production","volume":"65","author":"Benton","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.10.071_b0295","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/IAI.60.1.111-116.1992","article-title":"Strong association between capsular type and virulence for mice among human isolates of Streptococcus pneumoniae","volume":"60","author":"Briles","year":"1992","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.10.071_b0300","doi-asserted-by":"crossref","first-page":"566","DOI":"10.4049\/jimmunol.169.1.566","article-title":"Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle","volume":"169","author":"Kozlowski","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2016.10.071_b0305","doi-asserted-by":"crossref","first-page":"7047","DOI":"10.1016\/j.vaccine.2010.08.017","article-title":"Long-term immunity against pertussis induced by a single nasal administration of live attenuated B. pertussis BPZE1","volume":"28","author":"Feunou","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.10.071_b0310","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1097\/01.inf.0000160914.59160.41","article-title":"Duration of immunity against pertussis after natural infection or vaccination","volume":"24","author":"Wendelboe","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2016.10.071_b0315","doi-asserted-by":"crossref","DOI":"10.4161\/21645515.2014.990861","article-title":"Synchrony in serum antibody response to conserved proteins of Streptococcus pneumoniae in young children","author":"Ren","year":"2015","journal-title":"Human Vaccines Immunotherapeutics"},{"key":"10.1016\/j.vaccine.2016.10.071_b0320","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1084\/jem.79.2.137","article-title":"Studies on the chemical nature of the substance inducing transformation of pneumococcal types: induction of transformation by a desoxyribonucleic acid fraction isolated from pneumococcus type III","volume":"79","author":"Avery","year":"1944","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2016.10.071_b0325","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0882-4010(95)90125-6","article-title":"Virulence of Streptococcus pneumoniae in mice: a standardized method for preparation and frozen storage of the experimental bacterial inoculum","volume":"18","author":"Aaberge","year":"1995","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2016.10.071_b0330","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1084\/jem.158.2.559","article-title":"Identification of an active disaccharide unit of a glycoconjugate receptor for pneumococci attaching to human pharyngeal epithelial cells","volume":"158","author":"Andersson","year":"1983","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2016.10.071_b0335","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1084\/jem.116.4.491","article-title":"Release of genetic transforming agent from pneumococcal cultures during growth and disintegration","volume":"116","author":"Ottolenghi","year":"1962","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2016.10.071_b0340","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00035-12","article-title":"Nontypeable pneumococci can be divided into multiple cps types, including one type expressing the novel gene pspK","volume":"3","author":"Park","year":"2012","journal-title":"MBio"},{"key":"10.1016\/j.vaccine.2016.10.071_b0345","doi-asserted-by":"crossref","first-page":"58","DOI":"10.7774\/cevr.2013.2.1.58","article-title":"Inactivated pep27 mutant as an effective mucosal vaccine against a secondary lethal pneumococcal challenge in mice","volume":"2","author":"Choi","year":"2013","journal-title":"Clin Exp Vaccine Res"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16310209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16310209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,27]],"date-time":"2020-09-27T10:04:22Z","timestamp":1601201062000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16310209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":69,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0264410X16310209"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.10.071","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pneumococcal pep27 mutant immunization stimulates cytokine secretion and confers long-term immunity with a wide range of protection, including against non-typeable strains","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.10.071","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}